NCT03000257 2022-04-14A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid TumorsAbbViePhase 1 Completed182 enrolled
NCT02391480 2019-11-29A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With CancerAbbViePhase 1 Completed128 enrolled